Jim Sullivan

544 total citations
8 papers, 419 citations indexed

About

Jim Sullivan is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Jim Sullivan has authored 8 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Neurology. Recurrent topics in Jim Sullivan's work include Cancer therapeutics and mechanisms (3 papers), Neuroblastoma Research and Treatments (3 papers) and Neutropenia and Cancer Infections (2 papers). Jim Sullivan is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Neuroblastoma Research and Treatments (3 papers) and Neutropenia and Cancer Infections (2 papers). Jim Sullivan collaborates with scholars based in United States, United Kingdom and Canada. Jim Sullivan's co-authors include Mark L. Bernstein, Robert J. Hayashi, Donna A. Wall, Robert L. Saylors, Kimo C. Stine, Michael B. Harris, James L. Kepner, Susan M. Blaney, Eric M. Lasater and Steve Weitman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Journal of General Physiology.

In The Last Decade

Jim Sullivan

8 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jim Sullivan United States	6	216	177	162	149	83	8	419
Shigemichi Hirose Japan	10	81 0.4×	82 0.5×	163 1.0×	112 0.8×	61 0.7×	36	376
Amy Watkins United Kingdom	10	124 0.6×	88 0.5×	145 0.9×	83 0.6×	65 0.8×	17	405
J Shimizu Japan	7	72 0.3×	123 0.7×	116 0.7×	291 2.0×	73 0.9×	17	476
M Schlumberger France	11	119 0.6×	125 0.7×	50 0.3×	255 1.7×	133 1.6×	40	700
Cormac Owens Ireland	12	130 0.6×	221 1.2×	117 0.7×	107 0.7×	55 0.7×	40	419
Toshiaki Sano Japan	12	66 0.3×	182 1.0×	129 0.8×	54 0.4×	127 1.5×	16	518
Andy Gillespie United States	9	93 0.4×	214 1.2×	213 1.3×	149 1.0×	78 0.9×	13	468
Maria Giulia Pirini Italy	10	81 0.4×	66 0.4×	225 1.4×	83 0.6×	103 1.2×	26	418
Simon Schimmack Germany	17	136 0.6×	223 1.3×	62 0.4×	460 3.1×	167 2.0×	41	746
Anne Winther‐Larsen Denmark	14	114 0.5×	41 0.2×	226 1.4×	177 1.2×	33 0.4×	40	501

Countries citing papers authored by Jim Sullivan

Since Specialization

Citations

This map shows the geographic impact of Jim Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Sullivan more than expected).

Fields of papers citing papers by Jim Sullivan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Sullivan. The network helps show where Jim Sullivan may publish in the future.

Co-authorship network of co-authors of Jim Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Jim Sullivan. A scholar is included among the top collaborators of Jim Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim Sullivan. Jim Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Pollard, John R., Stuart W. Hughes, Steven R. Cummings, et al.. (2016). Abstract 3711: Pre-clinical combinations of ATR and PARP inhibitors: Defining target patient populations and dose schedule. Cancer Research. 76(14_Supplement). 3711–3711. 4 indexed citations

Hayashi, Robert J., Susan M. Blaney, Jim Sullivan, et al.. (2003). Phase 1 Study of Paclitaxel Administered Twice Weekly to Children With Refractory Solid Tumors: A Pediatric Oncology Group Study. Journal of Pediatric Hematology/Oncology. 25(7). 539–542. 21 indexed citations

Souid, Abdul‐Kader, Ronald L. Dubowy, Susan M. Blaney, et al.. (2003). Phase I clinical and pharmacologic study of weekly cisplatin and irinotecan combined with amifostine for refractory solid tumors.. PubMed. 9(2). 703–10. 27 indexed citations

Blaney, Susan M., Stacey L. Berg, Charles B. Pratt, et al.. (2001). A phase I study of irinotecan in pediatric patients: a pediatric oncology group study.. PubMed. 7(1). 32–7. 98 indexed citations

Saylors, Robert L., Kimo C. Stine, Jim Sullivan, et al.. (2001). Cyclophosphamide Plus Topotecan in Children With Recurrent or Refractory Solid Tumors: A Pediatric Oncology Group Phase II Study. Journal of Clinical Oncology. 19(15). 3463–3469. 219 indexed citations

Kennedy, Frank, et al.. (2000). Evaluating the Role of Physical and Radiographic Examinations in Assessing Bullet Tract Termination for Gunshot Victims. The American Surgeon. 66(3). 296–301. 11 indexed citations

Sullivan, Jim & Eric M. Lasater. (1992). Sustained and transient calcium currents in horizontal cells of the white bass retina.. The Journal of General Physiology. 99(1). 85–107. 36 indexed citations

Horton, John, et al.. (1968). Comparison of a combination of 5-fluorouracil (NSC-19893), mitomycin C (NSC-26980), triethylenethiophosphoramide (NSC-6396), and fluoxymesterone (NSC-12165) with 5-fluorouracil alone in patients with advanced cancer.. PubMed. 52(5). 597–600. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact